Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy

Journal of Magnetic Resonance Imaging

Volumn 43, Issue 2, 2016, Pages 325-332

  Rosenkrantz, Andrew B ^a   Meng, Xiaosong ^a   Ream, Justin M ^a   Babb, James S ^a   Deng, Fang Ming ^a   Rusinek, Henry ^a   Huang, William C ^a   Lepor, Herbert ^a   Taneja, Samir S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apparent diffusion coefficient; diffusion weighted imaging; MRI; prostate biopsy; prostate cancer

Indexed keywords

DIAGNOSTIC IMAGING; HUMAN; IMAGE GUIDED BIOPSY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTERVENTIONAL ULTRASONOGRAPHY; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING;

HUMANS; IMAGE-GUIDED BIOPSY; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84961173782     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24983     Document Type: Article

References (37)

1. Hoeks CM, Barentsz JO, Hambrock T, et al., Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011; 261: 46-66.
2. Hoeks CM, Somford DM, van Oort IM, et al., Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study. Invest Radiol 2014; 49: 165-172.
3. Siddiqui MM, Rais-Bahrami S, Truong H, et al., Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013; 64: 713-719.
4. Vourganti S, Rastinehad A, Yerram NK, et al., Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012; 188: 2152-2157.
5. Kaufmann S, Kruck S, Kramer U, et al., Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies. Urol Int 2015; 94: 319-325.
6. Stamatakis L, Siddiqui MM, Nix JW, et al., Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 2013; 119: 3359-3366.
7. Loch R, Fowler K, Schmidt R, Ippolito J, Siegel C, Narra V,. Prostate magnetic resonance imaging: challenges of implementation. Curr Probl Diagn Radiol 2015; 44: 26-37.
8. Dickinson L, Ahmed HU, Allen C, et al., Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging 2013; 37: 48-58.
9. Vache T, Bratan F, Mege-Lechevallier F, Roche S, Rabilloud M, Rouviere O,. Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. Radiology 2014; 272: 446-455.
10. Bomers JG, Barentsz JO,. Standardization of multiparametric prostate MR imaging using PI-RADS. BioMed Res Int 2014; 2014: 431680.
11. Barentsz JO, Richenberg J, Clements R, et al., ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-757.
12. Rosenkrantz AB, Kim S, Lim RP, et al., Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 2013; 269: 482-492.
13. Junker D, Quentin M, Nagele U, et al., Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis. World J Urol 2014. [Epub ahead of print].
14. Vargas HA, Akin O, Afaq A, et al., Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol 2012; 188: 1732-1738.
15. Yerram NK, Volkin D, Turkbey B, et al., Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int 2012; 110 (Pt B): E783-E788.
16. Roethke MC, Kuru TH, Schultze S, et al., Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 2014; 24: 344-352.
17. Grey AD, Chana MS, Popert R, Wolfe K, Liyanage SH, Acher PL,. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting. BJU Int 2015; 115: 728-735.
18. Hambrock T, Somford DM, Huisman HJ, et al., Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011; 259: 453-461.
19. Park JJ, Kim CK, Park SY, Park BK, Lee HM, Cho SW,. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy. AJR Am J Roentgenol 2014; 202: W459-W465.
20. Giles SL, Morgan VA, Riches SF, Thomas K, Parker C, deSouza NM,. Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components. AJR Am J Roentgenol 2011; 196: 586-591.
21. Donati OF, Mazaheri Y, Afaq A, et al., Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 2014; 271: 143-152.
22. Peng Y, Jiang Y, Yang C, et al., Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score-a computer-aided diagnosis development study. Radiology 2013; 267: 787-796.
23. Rosenkrantz AB, Triolo MJ, Melamed J, Rusinek H, Taneja SS, Deng FM,. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy. J Magn Reson Imaging 2015; 41: 708-714.
24. Wysock JS, Rosenkrantz AB, Huang WC, et al., A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS Trial. Eur Urol 2014; 66: 343-351.
25. Rosenkrantz AB, Chandarana H, Hindman N, et al., Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection. Eur Radiol 2013; 23: 3170-3177.
26. Rosenkrantz AB, Geppert C, Grimm R, et al., Dynamic contrast-enhanced MRI of the prostate with high spatiotemporal resolution using compressed sensing, parallel imaging, and continuous golden-angle radial sampling: preliminary experience. J Magn Reson Imaging 2015; 41: 1365-1373.
27. Martin PR, Cool DW, Romagnoli C, Fenster A, Ward AD,. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: quantifying the impact of needle delivery error on diagnosis. Med Phys 2014; 41: 073504.
28. Sparks R, Bloch BN, Feleppa E, et al., Multiattribute probabilistic prostate elastic registration (MAPPER): application to fusion of ultrasound and magnetic resonance imaging. Med Phys 2015; 42: 1153-1163.
29. Fedorov A, Khallaghi S, Sanchez CA, et al., Open-source image registration for MRI-TRUS fusion-guided prostate interventions. Int J Comput Assist Radiol Surg 2015; 10: 925-934.
30. Zhou XH, Obuchowski NA, McClish DK,. Statistical methods in diagnostic medicine. 2nd ed. New York: Wiley Interscience; 2011.
31. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
32. Rosenkrantz AB, Taneja SS,. Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 2014; 202: 109-120.
33. Penzkofer T, Tuncali K, Fedorov A, et al., Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study. Radiology 2015; 274: 170-180.
34. Langer DL, van der Kwast TH, Evans AJ, et al., Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology 2008; 249: 900-908.
35. Rosenkrantz AB, Lim RP, Haghighi M, Somberg MB, Babb JS, Taneja SS,. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol 2013; 201: W612-W618.
36. Rosenkrantz AB, Rice SL, Wehrli NE, Deng FM, Taneja SS,. Association between changes in suspicious prostate lesions on serial MRI examinations and follow-up biopsy results. Clin Imaging 2015; 39: 264-269.
37. Leake JL, Hardman R, Ojili V, et al., Prostate MRI: access to and current practice of prostate MRI in the United States. J Am Coll Radiol 2014; 11: 156-160.